- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced or Metastatic NRAS-mutant Melanoma
Total 554 results
-
PfizerRecruitingMelanoma | Colorectal Cancer | Non-Small Cell Lung Cancer | Urothelial Cancer | Advanced or Metastatic Solid TumorsUnited States, Puerto Rico
-
Sheba Medical CenterRambam Health Care Campus; AstraZeneca; Tel-Aviv Sourasky Medical CenterRecruitingMetastatic or Locally Advanced NSCLCIsrael
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Not yet recruitingAdvanced or Metastatic NSCLCChina
-
Tracon Pharmaceuticals Inc.Active, not recruitingSoft Tissue Sarcoma | Advanced Sarcoma | Metastatic SarcomaUnited States
-
Rainier TherapeuticsTerminatedUrinary Bladder Disease | Locally Advanced or Metastatic Urothelial Cell Carcinoma | Urological DiseasesUnited States, Spain, Belgium, France, Germany, Italy, Korea, Republic of, Turkey, Hungary, Netherlands, Serbia, Poland, Russian Federation, Sweden, Moldova, Republic of, Denmark, Ukraine
-
Rainier TherapeuticsTerminatedUrinary Bladder Disease | Locally Advanced or Metastatic Urothelial Cell Carcinoma | Urological DiseasesItaly, Spain, United States, Korea, Republic of, Turkey, Taiwan, Sweden, Czechia, United Kingdom
-
iOMEDICO AGNovartis PharmaceuticalsCompletedCarcinoma, Renal Cell | Clear-cell Metastatic Renal Cell Carcinoma | Locally Advanced and/or Metastatic Renal Cell CarcinomaGermany
-
Herlev HospitalActive, not recruitingBorderline Resectable, Locally Advanced or Metastatic Pancreatic CancerDenmark
-
Palobiofarma SLOhio State UniversityActive, not recruiting
-
Seoul National University HospitalAstraZeneca; Korean Cancer Study GroupCompletedLocally Advanced or Metastatic NSCLCKorea, Republic of
-
AstraZenecaCompletedLocally Advanced or Metastatic NSCLCChina
-
Ascendis Pharma Oncology Division A/SRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Locally Advanced Solid Tumor | Neoadjuvant Melanoma | Head and Neck Squamous Cell Carcinoma HNSCC | HPV-associated Cancers | Neoadjuvant Cutaneous Squamous Cell Carcinoma (cSCC)United States, Australia, Spain, Netherlands, Korea, Republic of, Taiwan
-
Eli Lilly and CompanyCompletedColorectal Cancer | Metastatic Melanoma | Advanced Cancer | Metastatic Non-small Cell Lung CancerUnited States, Japan, Australia, France
-
OncoTherapy Science, Inc.RecruitingRelapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast CancerUnited States
-
BayerCompletedLocally Advanced or Metastatic Infantile Fibrosarcoma Harboring an NTRK Gene Fusion | Infantile FibrosarcomaFrance
-
The First Affiliated Hospital of Xiamen UniversityUnknownLocally Advanced or Metastatic Gastric AdenocarcinomaChina
-
German Breast GroupGlaxoSmithKline; Stemline Therapeutics, Inc.Not yet recruitingBRCA1 Mutation | BRCA2 Mutation | PALB2 Gene Mutation | Hormone Receptor Positive HER-2 Negative Breast Cancer | Advanced or Metastatic Breast CancerGermany
-
Suzhou Junjing BioSciences Co., Ltd.Sponsor GmbHRecruitingLocally Advanced or Metastatic NSCLCChina
-
Sarcoma Oncology Research Center, LLCBristol-Myers SquibbRecruitingSAINT:Trabectedin, Ipilimumab and Nivolumab as First Line Treatment for Advanced Soft Tissue SarcomaAdvanced Soft Tissue Sarcoma | Metastatic Soft Tissue SarcomaUnited States
-
Daiichi SankyoMerck Sharp & Dohme LLC; AstraZenecaActive, not recruitingAdvanced or Metastatic NSCLCUnited States, Spain, Taiwan, Japan, Italy
-
Italian Sarcoma GroupCompletedMetastatic and Locally Advanced Soft Tissue Tumor Patients Unfit to Receive | Standard ChemotherapyItaly
-
Eli Lilly and CompanyCompletedHistological or Cytological Diagnosis of Locally Advanced or Metastatic NSCLC of Nonsquamous Histology and Not Amenable to Curative Therapy.Hungary, Germany, Austria, Spain, Sweden
-
Emory UniversityNational Cancer Institute (NCI); GlaxoSmithKline; National Institutes of Health...Active, not recruitingMicrosatellite Stable | Stage IV Colorectal Cancer AJCC v8 | RAS Wild Type | MSI-H Colorectal Cancer | Metastatic Microsatellite Stable Colorectal Carcinoma | Advanced Microsatellite Stable Colorectal CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingPrognostic Stage IIIC Breast Cancer AJCC v8 | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Metastatic Melanoma | Stage IV Lung Cancer AJCC v8 | Locally Advanced Malignant Solid Neoplasm | Locally... and other conditionsUnited States
-
Grupo Espanol Multidisciplinario del Cancer DigestivoCompletedAdvanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (Relapsed After a Cisplatin Based Treatment)Spain
-
Shanghai JMT-Bio Inc.Not yet recruiting
-
AkesoNot yet recruitingLocally Advanced or Metastatic NSCLCChina
-
GWT-TUD GmbHCompletedAdvanced Soft-tissue Sarcoma | Metastatic Soft-tissue SarcomaGermany, Austria, Switzerland
-
Jiangsu Aosaikang Pharmaceutical Co., Ltd.UnknownLocally Advanced or Metastatic NSCLCChina
-
Merrimack PharmaceuticalsSanofiCompletedLocally Advanced/Metastatic or Recurrent Ovarian Cancer, Fallopian Tube Cancer, | Primary Peritoneal Cancer or Endometrial Cancer | Locally Advanced/Metastatic Her2 Non Overexpressing Breast CancerUnited States
-
Novartis PharmaceuticalsRecruitingMSIhi or dMMR Advanced Unresectable or Metastatic Solid Tumors, Including Colorectal CancersJapan, Italy, Spain, Singapore, Belgium, Germany, Korea, Republic of, Sweden, Taiwan, France, Israel, Norway, United States
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.RecruitingHase 1/2 Study of HS-10375 in Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC)Advanced or Metastatic NSCLCChina
-
AstraZenecaDaiichi SankyoRecruitingAdvanced or Metastatic NSCLCUnited States, Taiwan, Italy, Poland, Spain, Japan, Belgium, Turkey, France, Korea, Republic of
-
AstraZenecaActive, not recruitingAdvanced or Metastatic NSCLCRussian Federation
-
Novartis PharmaceuticalsNovartisWithdrawnTreatment for Metastatic or Locally Advanced Cervical CancerBrazil
-
Jules Bordet InstituteHoffmann-La RocheRecruitingMetastatic Colorectal Cancer | Unresectable Locally Advanced Colorectal Cancer | Candidate for Third-line or Subsequent Lines of TherapyBelgium, France
-
Hoffmann-La RocheTerminatedEstrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast CancerCanada, United States, United Kingdom, Australia, Germany
-
Institut du Cancer de Montpellier - Val d'AurelleFondazione IRCCS ISTITUTO NAZIONALE TUMORIWithdrawnHealthy | Non-small Cell Lung Cancer Stage III | Squamous Cell Carcinoma of Head and Neck | Metastatic Breast Cancer | Metastatic Melanoma | Advanced Renal Cell Carcinoma
-
Peking Union Medical CollegePeking University Hospital of StomatologyRecruitingPrecision Therapy | Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma | Neoadjuvant or Conversion TherapyChina
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedAdvanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell CarcinomaUnited States, France, Canada, Spain, Italy, Belgium, Austria, Denmark, Germany, Australia, Israel, Russian Federation, Czechia, Norway, Poland, Romania, Japan, Argentina, Ireland, Greece, United Kingdom, Brazil, Sweden, Finland
-
Central Hospital, Nancy, FranceUnknownMelanoma | Skin Cancer | Oncology | Skin Squamous Cell Carcinoma | Advance Directives | Skin Lymphoma | Metastatic Basal Cell CarcinomaFrance
-
iOMEDICO AGRoche Pharma AGCompletedExtensive-stage Small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Advanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBCGermany
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingAdvanced or Metastatic Renal Cell CarcinomaJapan
-
Allarity TherapeuticsCompletedPhase 1: Advanced or Refractory Solid Tumours | Phase 2 Part: Metastatic Breast Cancer, Prostate Cancer and Skin CancerDenmark
-
AstraZenecaTerminatedSubjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GCFinland
-
Taiho Oncology, Inc.RecruitingAdvanced or Metastatic NSCLS With Exon 20 Insertion MutationUnited States, Spain, Canada, Italy, Israel, Japan, United Kingdom, Korea, Republic of, Germany, France, Turkey, Belgium, Netherlands, Philippines, Poland, Singapore
-
Shanghai JMT-Bio Inc.Active, not recruitingLocal Advanced or Metastatic NSCLC | Harboring EGFR Common MutationChina
-
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Not yet recruitingAdvanced or Metastatic Non-squamous Non-small Cell Lung Cancer
-
NextCure, Inc.WithdrawnNon-Small Cell Lung Cancer | Advanced or Metastatic Solid Tumors
-
AbbVie (prior sponsor, Abbott)Genentech, Inc.CompletedAdvanced or Metastatic Non-Small Cell Lung CancerUnited States, Australia, Brazil, Czech Republic, Russian Federation, Singapore